Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paula Askalsky"'
Autor:
Charles R. Marmar, Edward M. Kantor, Paula Askalsky, James C. West, Rahn K. Bailey, Frederick J. Stoddard
Publikováno v:
Psychiatric Annals. 50:301-305
In January 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, was identified as the causative agent for pneumonia cases in the Hubei Province of China. By March 11, 2020, coronavirus disease 2019 (COVID-19) reach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f113d1ca80aa18d799d00ffefd15d269
https://doi.org/10.3928/00485713-20200610-01
https://doi.org/10.3928/00485713-20200610-01
Publikováno v:
Journal of the Academy of Consultation-Liaison Psychiatry. 63:S135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94a943a688f6fbaa9e9f6b918f478c46
https://doi.org/10.1016/j.jaclp.2022.10.049
https://doi.org/10.1016/j.jaclp.2022.10.049
Autor:
Paula Askalsky, Dan V. Iosifescu
Publikováno v:
Neuropsychiatric Disease and Treatment. 15:3255-3272
Major depressive disorder (MDD) is a prevalent condition associated with high rates of disability, as well as suicidal ideation and behavior. Current treatments for MDD have significant limitations in efficacy and side effect burden. FDA-approved dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbe8fd9d9eee99b9061ae1f2458e9ad5
https://doi.org/10.2147/ndt.s188906
https://doi.org/10.2147/ndt.s188906
Publikováno v:
Pharmacol Biochem Behav
Background Recent data suggest that glial cells may be involved in the analgesic effects and abuse liability of opioids. Preclinical studies have demonstrated that mu-opioid-receptor-selective agonists, such as oxycodone, activate glia and increase t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b4fff7fd77d2924ab5dd10f596bbffb
https://doi.org/10.1016/j.pbb.2021.173241
https://doi.org/10.1016/j.pbb.2021.173241
Autor:
Ziva D. Cooper, Suzanne K. Vosburg, Richard W. Foltin, Margaret Haney, Jermaine D. Jones, Paula Askalsky, Eric J. Rubin, Diana Martinez, Sandra D. Comer, Abigail Pines, Perrine Roux, Emily L Berkower, Phillip A. Saccone, Ellen A. Walker, Shanthi Mogali, Jeanne M. Manubay, Maria A. Sullivan
Publikováno v:
Neuropsychopharmacology. 38:2427-2438
Despite the prevalent worldwide abuse of stimulants, such as amphetamines and cocaine, no medications are currently approved for treating this serious public health problem. Both preclinical and clinical studies suggest that the opioid antagonist nal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2afa7cea044d2e255e0f1a642c388dc
https://doi.org/10.1038/npp.2013.143
https://doi.org/10.1038/npp.2013.143
Butyrylcholinesterase (BChE) is beginning to attract attention as a possible target for cocaine abuse treatment because of its role in metabolizing cocaine.The purpose of this analysis was to assess whether endogenous BChE levels are associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c571059fdcbdd459746e060d2dba6f
https://europepmc.org/articles/PMC4336628/
https://europepmc.org/articles/PMC4336628/
